Some of December's Most Interesting Stocks

HENDERSON, NV / ACCESSWIRE / December 4, 2018 / The following stocks in the CBD/Biotech sectors look poised for big December's.

Today we are highlighting: BioRestorative Therapies, Inc. (BRTX), CV Sciences, Inc. (CVSI), Liberty Health Sciences, Inc. (LHSIF), Corbus Pharmaceuticals, Inc. (CRBP), and Novavax (NVAX).

The American Medical Association just reported 6 states saw obesity rates rise, bringing the number of states above 35% rate to 7 (Alabama, Arkansas, Iowa, Louisiana, Mississippi, Oklahoma, West Virginia.)

Obesity costs the US $1.72 Trillion annually between healthcare costs and decreased productivity. Companies with winning remedies to this problem will see their market cap grow like their potential patients' waists.

One interesting company tackling this issue is BioRestorative Therapies, Inc. (BRTX) (Market Cap: $7.609M Share Price: $0.77), a life sciences company focused on stem cell-based therapies, developing a therapy "ThermoStem" using brown adipose (fat) derived stem cells to generate brown adipose tissue ("BAT"). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.

BRTX just received a Notice of Allowance on the company's fourth patent for their metabolic ThermoStem program. The company's patents span US, Australia and Japan.

Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. This is a very promising sign for the company.

CBD is being studied as a treatment for several conditions. CBD company, CV Sciences, Inc. (CVSI) (Market Cap: $475.764M Share Price: $5.03), announced its financial results for the third quarter ended September 30, 2018. These included sales of $13,600,000 (an increase of 143% compared to Q3 2017), gross profit of $9,945,000 (an increase of 149% compared to Q3 2017), and achieved industry's first hemp extract self-affirmed Generally Recognized as Safe status for its hemp-derived CBD gold extract product line.

Another play in the same industry, Liberty Health Sciences, Inc. (LHSIF) (Market Cap: $317.305 Share Price: $0.93), just announced that it plans to open two new dispensaries in Miami and Dania Beach by the end of November and three more in Hollywood, Bonita Springs and Orange Park by the end of this December. Each of the dispensaries will feature free 24-hour delivery service throughout their service area.

Another healthcare stock like BRTX to pay attention to, Corbus Pharmaceuticals, Inc. (CRBP). (Market Cap: $394.366M Share Price: $6.89), a clinical stage drug development company with the industry leading pipeline focused on treating inflammatory and fibrotic diseases through the endocannabinoid system ("ECS") pathways, recently announced its financial results for the third quarter ended September 30, 2018 along with updates on recent milestones. CRBP reported quarterly loss of $0.26. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.

Novavax, Inc. (NVAX) (Market Cap: $838.441M Share Price: $2.19) recently announced several key management promotions while the company pushes its lead clinical programs into commercial stage. The company is pushing their ResVax and NanoFlu programs towards licensure.

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to receive a $90,000 convertible note with the issuer for 90 days of service dated 7/10/18. Regal Consulting has signed an amendment to the agreement dated 7/10/18, to extend the agreement and provide additional services for an additional $80,000 convertible note with the issuer. Regal Consulting has signed a second amendment to add additional services for an additional $90,000 convertible note. All payments were made directly by BioRestorative Therapies, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspecultors.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. BRTX was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/.

Microspeculators.com Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators
Contact Person: Media Manager
Email: [email protected]
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/

SOURCE: Regal Consulting, LLC